These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38365538)
1. Corrigendum to "Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis". [Int. Immunopharmacol. 113(Pt B) (2022) 109422]. Cang W; Wu A; Gu L; Wang W; Tian Q; Zheng Z; Qiu L Int Immunopharmacol; 2024 Mar; 129():111651. PubMed ID: 38365538 [No Abstract] [Full Text] [Related]
2. Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis. Cang W; Wu A; Gu L; Wang W; Tian Q; Zheng Z; Qiu L Int Immunopharmacol; 2022 Dec; 113(Pt B):109422. PubMed ID: 36410184 [TBL] [Abstract][Full Text] [Related]
3. Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells. Battaglia AM; Sacco A; Perrotta ID; Faniello MC; Scalise M; Torella D; Levi S; Costanzo F; Biamonte F Front Oncol; 2022; 12():868351. PubMed ID: 35433479 [TBL] [Abstract][Full Text] [Related]
4. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo. Cheng Q; Bao L; Li M; Chang K; Yi X J Obstet Gynaecol Res; 2021 Jul; 47(7):2481-2491. PubMed ID: 33882617 [TBL] [Abstract][Full Text] [Related]
5. Corrigendum to "Salidroside postconditioning attenuates ferroptosis-mediated lung ischemia-reperfusion injury by activating the Nrf2/SLC7A11 signaling axis" [Int. Immunopharmacol. 115 (2023) 109731]. Wang Y; Chen Z; Luo J; Zhang J; Sang AM; Cheng ZS; Li XY Int Immunopharmacol; 2023 Apr; 117():110002. PubMed ID: 36925352 [No Abstract] [Full Text] [Related]
6. Corrigendum to "Liproxstatin-1 alleviates LPS/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis" [Int. Immunopharmacol. 109 (2022) 108770]. Bao C; Liu C; Liu Q; Hua L; Hu J; Li Z; Xu S Int Immunopharmacol; 2023 Feb; 115():109482. PubMed ID: 36610897 [No Abstract] [Full Text] [Related]
7. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance. Liu N; Lin X; Huang C Br J Cancer; 2020 Jan; 122(2):279-292. PubMed ID: 31819185 [TBL] [Abstract][Full Text] [Related]
8. Corrigendum to "Isosteviol reduces acute inflammatory response after burn injurys by upregulating MMP9 in macrophages, leading to M2 polarization" [Int. Immunopharmacol. 106 (2022) 108609]. Qiao G; Ji W; Sun Z; Wang X; Li P; Jia H; Duan L; Qi F Int Immunopharmacol; 2022 Dec; 113(Pt B):109414. PubMed ID: 36402673 [No Abstract] [Full Text] [Related]
9. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis. Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839 [TBL] [Abstract][Full Text] [Related]
10. Butyrate enhances erastin-induced ferroptosis of lung cancer cells via modulating the ATF3/SLC7A11 pathway. Bi R; Hu R; Jiang L; Wen B; Jiang Z; Liu H; Mei J Environ Toxicol; 2024 Feb; 39(2):529-538. PubMed ID: 37341073 [TBL] [Abstract][Full Text] [Related]
11. Ferroptosis-dependent breast cancer cell-derived exosomes inhibit migration and invasion of breast cancer cells by suppressing M2 macrophage polarization. Yi C; Wu S; Duan Q; Liu L; Li L; Luo Y; Wang A PeerJ; 2023; 11():e15060. PubMed ID: 36949762 [TBL] [Abstract][Full Text] [Related]
12. MiR-217 Inhibits M2-Like Macrophage Polarization by Suppressing Secretion of Interleukin-6 in Ovarian Cancer. Jiang B; Zhu SJ; Xiao SS; Xue M Inflammation; 2019 Oct; 42(5):1517-1529. PubMed ID: 31049770 [TBL] [Abstract][Full Text] [Related]
13. Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer. Zhou HH; Chen X; Cai LY; Nan XW; Chen JH; Chen XX; Yang Y; Xing ZH; Wei MN; Li Y; Wang ST; Liu K; Shi Z; Yan XJ Front Oncol; 2019; 9():1398. PubMed ID: 31921655 [TBL] [Abstract][Full Text] [Related]
14. Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis. Ning Y; Feng W; Cao X; Ren K; Quan M; Chen A; Xu C; Qiu Y; Cao J; Li X; Luo X J Exp Clin Cancer Res; 2019 Jan; 38(1):19. PubMed ID: 30646963 [TBL] [Abstract][Full Text] [Related]
15. Corrigendum to "HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils" [Int. Immunopharmacol. 94 (2021) 107433]. Zhang J; Li Q; Zou YR; Wu SK; Lu XH; Li GS; Wang J Int Immunopharmacol; 2021 Aug; 97():107573. PubMed ID: 33745852 [No Abstract] [Full Text] [Related]
16. Corrigendum to "HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils" [Int. Immunopharmacol. 94 (2021) 107433]. Zhang J; Li Q; Zou YR; Wu SK; Lu XH; Li GS; Wang J Int Immunopharmacol; 2022 Mar; 104():108461. PubMed ID: 34991980 [No Abstract] [Full Text] [Related]
17. [Role of Nrf2/GPX4 mediated ferroptosis in intestinal injury in sepsis]. Ma T; Huang W; Li Z; Wang Y; Gao X; Yu X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Nov; 35(11):1188-1194. PubMed ID: 37987130 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression. Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745 [TBL] [Abstract][Full Text] [Related]
19. MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells. Gai C; Liu C; Wu X; Yu M; Zheng J; Zhang W; Lv S; Li W Cell Death Dis; 2020 Sep; 11(9):751. PubMed ID: 32929075 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells. Bai T; Liang R; Zhu R; Wang W; Zhou L; Sun Y J Cell Physiol; 2020 Jul; 235(7-8):5637-5648. PubMed ID: 31960438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]